Refractory Gray-Zone Lymphoma

specific

A gray-zone lymphoma that is resistant to treatment.

26

Centers

14

Active Trials

Cancer Funding

Top Centers for Refractory Gray-Zone Lymphoma(26)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
62.3
2
NCI Comprehensive
Active Research Program
62.3
3
NCI Comprehensive
Active Research Program
62.3
4
NCI Comprehensive
Active Research Program
62.3
5
NCI Comprehensive
Active Research Program
62.3
6
NCI Comprehensive
Active Research Program
62.3
7
NCI Comprehensive
Active Research Program
62.3
8
NCI Comprehensive
Active Research Program
62.3
9
NCI Comprehensive
Active Research Program
62.3
10
NCI Comprehensive
Active Research Program
62.3
11
Active Research Program
62.3
12
Active Research Program
62.3
13
Active Research Program
62.3
14
Active Research Program
62.3
15
NCI Comprehensive
39.8
1639.8
17
NCI Comprehensive
39.8
18
NCI Comprehensive
39.8
1939.8
2039.8
21
NCI Comprehensive
39.8
22
NCI Comprehensive
39.8
23
NCI Comprehensive
39.8
2439.8
25
NCI Comprehensive
39.8
2639.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →